NYSE · Drug Manufacturers - Specialty & Generic

Haleon plc (HLN) Stock

$9.76 +0.51% NYSE: HLN Healthcare

Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region.

Valuation

MetricValue
Price$9.76
Market Cap$42.98B
P/E Ratio19.49
P/B Ratio1.98
P/S Ratio2.89
EPS (TTM)$0.50
52-Week High$11.28
52-Week Low$8.65
Dividend Yield2.77%

Financials & Margins

MetricValue
ROE10.30%
ROA5.11%
ROCE8.71%
Gross Margin64.77%
Operating Margin21.87%
Net Margin15.11%
Debt/Equity0.52
Current Ratio0.92

Annual Financials (USD)

Metric20212022202320242025
Revenue$9.5B$10.9B$11.3B$11.2B$11.0B
Operating Profit$1.6B$1.8B$2.0B$2.2B$2.4B
Net Profit$1.4B$1.1B$1.0B$1.4B$1.6B
EPS$0.30$0.24$0.24$0.32$0.36
Op Margin17.2%16.8%17.7%19.6%21.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$34.5B$34.8B$34.1B$34.3B$32.6B
Total Liabilities$8.0B$18.4B$17.3B$18.1B$16.1B
Cash$414.0M$684.0M$1.0B$2.2B$1.3B
Borrowings$991.0M$10.4B$9.5B$10.1B$8.6B

Latest News

Haleon (HLN) Partners with Microsoft (MSFT) to Advance Digital and AI Capabilities Insider Monkey · Jul 12, 2026 Haleon Signs a Five-Year Agreement With Microsoft (MSFT) to Deploy Agentic AI Across Its Global Operations Insider Monkey · Jul 9, 2026 From shampoo to cookies, consumer products get an AI makeover Reuters · Jul 6, 2026 Kyndryl Expands Sovereignty Solutioning with Microsoft (MSFT) Insider Monkey · Jul 2, 2026 Haleon Just Struck a Five-Year Deal With Microsoft. Here Is What It Means for Haleon Stock. Barchart · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$1.4B$2.1B$2.1B$2.3B$2.3B
Investing Cash Flow$-331.0M$-9.1B$-470.0M$278.0M$-882.0M
Financing Cash Flow$-96.0M$107.0M$-627.0M$-1.6B$-679.0M
Net Cash Flow$82.0M$205.0M$383.0M$1.2B$-770.0M
Free Cash Flow$1.1B$1.7B$1.8B$2.1B$2.0B

Valuation & Return Ratios

MetricValue
PEG Ratio1.04
EV / EBITDA13.96
FCF Yield7.26%
Quick Ratio0.71
Interest Coverage7.24
Return 1Y7.88%
Return 3Y21.17%
Return 5Y—

Ownership

Insiders Held0.01%
Institutions Held13.28%
Institutions Float Held13.28%
Institutional HolderSharesReport Date
Dodge & Cox Inc.146,539,6632026-03-31
FMR, LLC113,969,1592026-03-31
ClearBridge Investments, LLC31,718,7252026-03-31
Morgan Stanley19,166,2532026-03-31
Harding Loevner LP15,712,5502026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAgilent Technologies, Inc. $137.39 -0.85% 25.52 $38.80B 0.59%
ALCAlcon Inc. $69.11 +2.72% 38.28 $33.70B 0.44%
BDXBecton, Dickinson and Company $168.40 +1.24% 26.08 $61.01B 2.58%
CAHCardinal Health, Inc. $229.12 -1.46% 34.93 $53.66B 0.89%
HUMHumana Inc. $364.54 -6.22% 29.34 $43.77B 0.96%

About Haleon plc

Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.

Haleon plc is headquartered in GB.

Haleon plc (HLN) stock trades at $9.76 with a market capitalization of $42.98B. The stock is valued at a price-to-earnings (P/E) ratio of 19.49, price-to-book of 1.98, price-to-sales of 2.89. Over the past 52 weeks the stock has ranged between $8.65 and $11.28, and currently trades 13.5% below its 52-week high. It pays a dividend yielding 2.77%.

On profitability, Haleon plc generates a return on equity (ROE) of 10.30%, return on capital employed of 8.71%, an operating margin of 21.87%, a net profit margin of 15.11%.

In its most recent fiscal year, Haleon plc reported annual revenue of $11.0B, net profit of $1.6B, revenue has compounded at 2.2% a year over the last five years, profit at 7.3% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.52, a current ratio of 0.92, total assets of $32.6B, $1.3B in cash and equivalents.

HLN has an average daily trading volume of 9,083,786 shares, a beta of 0.24 (less volatile than the overall market).

Official website: www.haleon.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides